Inogen reported $35.01M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US $ 6908M 160M
Abiomed ABMD:US $ 218.39M 4.84M
Accuray ARAY:US $ 34.78M 7.84M
Atricure ATRC:US $ 55.6M 0.58M
Baxter International BAX:US $ 1350M 58M
Becton, Dickinson and BDX:US $ 2305M 118M
Boston Scientific BSX:US $ 2059M 85M
Cardiovascular Systems CSII:US $ 41.43M 0.37M
Chart Industries GTLS:US $ 83.9M 1.7M
Cooper Companies COO:US $ 518.4M 16.5M
Dexcom DXCM:US $ 398.1M 102.6M
Edwards Lifesciences EW:US $ 1041.9M 21.7M
Globus Medical GMED:US $ 171.38M 16.84M
Inogen INGN:US $ 35.01M 3.58M
Insulet PODD:US $ 209.7M 3.5M
Invacare IVC:US $ 47.73M 15.61M
Masimo MASI:US $ 204.76M 10.13M
Medtronic MDT:US $ 5330M 20M
Natus Medical BABY:US $ 73.04M 5.4M
Philips PHIA:NA € 1918M 56M
Resmed RMD:US $ 491.2M 13.12M
Steris STE:US $ 538.11M 57.77M
Stryker SYK:US $ 2727M 272M
Tandem Diabetes Care TNDM:US $ 91.09M 22.64M
Teleflex TFX:US $ 346.23M 73.5M
Zimmer Biomet Holdings Inc ZBH:US $ 1.16B 213.2M